SCHEMBL7416702

SCHEMBL7416702

COc1ccc(S(=O)(=O)NC(C)CC(=O)NO)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEP1B Q16820 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.57
MMP2 P08253 11/20 0.56
MMP3 P08254 9/20 0.56
PDE4A P27815 4/20 0.56
PDE4B Q07343 4/20 0.56
PDE4C Q08493 4/20 0.56
PDE4D Q08499 4/20 0.56
MMP1 P03956 10/20 0.56
ALDH1A1 P00352 1/20 0.55
POLB P06746 1/20 0.55
LMNA P02545 1/20 0.54
MMP9 P14780 3/20 0.54
MMP8 P22894 2/20 0.54
MMP13 P45452 2/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
MMP7 P09237 1/20 0.53
CA12 O43570 1/20 0.52
CA9 Q16790 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7461425 0.85 MEP1B (0.56) MEP1BMMP2MMP3PDE4APDE4B
SCHEMBL7411095 0.84 MMP1 (0.65) SMN1; SMN2MMP2MMP3PDE4AMMP1
SCHEMBL7418100 0.84 MMP2 (0.55) SMN1; SMN2MMP2MMP3MMP1ALDH1A1
SCHEMBL7413723 0.81 MEP1B (0.62) MEP1BMMP2MMP3PDE4APDE4B
SCHEMBL6324010 0.81 ALDH1A1 (0.62) SMN1; SMN2MMP2MMP3MMP1ALDH1A1
SCHEMBL6324013 0.81 ALDH1A1 (0.62) SMN1; SMN2MMP2MMP3MMP1ALDH1A1
SCHEMBL6321535 0.81 ALDH1A1 (0.62) SMN1; SMN2MMP2MMP3MMP1ALDH1A1
SCHEMBL7410702 0.81 PDE4A (0.67) MEP1BMMP2MMP3PDE4APDE4B
SCHEMBL23518077 0.79 SMN1; SMN2 (0.68) SMN1; SMN2MMP2MMP3MMP1ALDH1A1
SCHEMBL7417565 0.78 MMP9 (0.64) SMN1; SMN2MMP2MMP3MMP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed